With years of experience in the Pharmaceutical and life science sectors, CD Bioparticles announces the launch of its new line ...

how do online casino welcome bonuses work InnoCare Pharma submits first new drug Obutinib for marketing approval The synergistic effect of anti-angiogenic drugs combined with cancer immunotherapy has ...

Surufatinib is under clinical development by Hutchison MediPharma and currently in Phase II for Epithelial Ovarian Cancer.

Lenvatinib mesylate is under clinical development by Eisai and currently in Phase III for Gastric Cancer. According to GlobalData, Phase III drugs for Gastric Cancer have a 46% phase transition ...

The synergistic effect of anti-angiogenic drugs combined with cancer immunotherapy has been proven again! Analysis of the current status of clinical research on rare diseases: Big data has its ...

There are many different ways lifestyle diseases can be classified or grouped. Here is the way I like to group them: (1) ...

Potential trials may include sorafenib, capecitabine and lapatinib for HER-2-positive MBC and the use of sorafenib as an anti-angiogenic agent in the adjuvant setting of early-stage breast cancer.

After hours: December 31 at 7:21:05 PM EST ...

Image design copyright Bree Buttenshaw for Saltwater People (2024). Developed by the Australian Human Rights Commission with dedicated funding from the Australian Government, the National Anti-Racism ...

Stop hackers and malicious software in their tracks with the best device protection. Here are CNET's top picks for antivirus software to improve your digital security. Dianna Gunn built her first ...

The content of this image is as provided and cannot be independently verified. (Korean Central News Agency/Korea News Service via AP) SEOUL, South Korea (AP) — North Korean leader Kim Jong Un vowed to ...

After hours: 7:21:05 p.m. EST ...